
Copyright © 2025 KAP
Central Securities Depository & Trade Repository of Türkiye
| ||||||||||||||||||||||
General Assembly Invitation | ||||||||||||||||||||||
| ||||||||||||||||||||||
Agenda Items | ||||||||||||||||||||||
1 - Opening, formation of Meeting Presidency and authorizing Meeting Presidency to sign Meeting Minutes. | ||||||||||||||||||||||
2 - Reading, discussing and approving the Annual Activity Report for the fiscal period January 1, 2024, and December 31, 2024 that was prepared by the Company's Board of Directors. | ||||||||||||||||||||||
3 - Reading the Independent Audit Report for the fiscal period January 1, 2024, and December 31, 2024, without submitting to vote and a resolution | ||||||||||||||||||||||
4 - Reading, discussing and approving the Financial Statements for the fiscal period January 1, 2024, and December 31, 2024. | ||||||||||||||||||||||
5 - Release of each member of the Board of Directors and managers in relation to the activities and transactions of Company in the fiscal period January 1, 2024, and December 31, 2024. | ||||||||||||||||||||||
6 - Reading, discussing and approving the Board of Directors' proposal for Dividend Distribution Policy for the fiscal period January 1, 2024, and December 31, 2024. | ||||||||||||||||||||||
7 - Determining remuneration for the Members of the Board of Directors. | ||||||||||||||||||||||
8 - Determination of the number and duty term of the Members of the Board of Directors, making elections to serve in determined terms. | ||||||||||||||||||||||
9 - Discussing and approving of the Independent Auditing Institution selected by the Board of Directors in accordance with the Turkish Commercial Code and the Capital Markets Board regulations. | ||||||||||||||||||||||
10 - Discussion and Approval of the Board of Directors' Proposal on the Election of the Sustainability Auditor in Accordance with the Turkish Commercial Code, the Sustainability Audit Regulation, and Related Legislative Provisions. | ||||||||||||||||||||||
11 - Approving the authorization of Members of the Board of Directors to carry out transactions stated in the articles 395 and 396 of the Turkish Commercial Code. | ||||||||||||||||||||||
12 - Discussing and approving the authorization of the Board of Directors to issue debt instruments (including warrants) with the permission of the Capital Markets Board and up to an amount allowed by the Turkish Commercial Code, the Capital Markets Law, the Capital Markets Legislation and related legislations and to determine issue date and conditions until the Ordinary General Assembly that will be held to discuss activities and accounts for the fiscal period January 1, 2025 and December 31, 2025. | ||||||||||||||||||||||
13 - Discussing and approving the authorization of the Board of Directors to distribute dividend in advance and to determine date and conditions of such distribution and in case where there is not enough profit or loss occurs at the end of the relevant accounting period, the advance dividend to be distributed shall be offset from the resources that can be subject to profit distribution in the annual financial statements for the relevant accounting period within the framework of the Company's Articles of Association, Turkish Commercial Code, the Capital Markets Law, the Capital Markets Legislation and related legislations. | ||||||||||||||||||||||
14 - Discussion and Approval of the Board of Directors' Proposal on the Share Buyback Program in Accordance with the Turkish Commercial Code and Capital Markets Legislation. | ||||||||||||||||||||||
15 - Determination of maximum limit for donations that shall be valid until the Ordinary General Assembly that will be held to discuss activities and accounts for the fiscal period January 1, 2025 and December 31, 2025, in accordance with the Company's Articles of Association and the Board of Director's proposal and discussing and approving to authorize the Board of Directors. | ||||||||||||||||||||||
16 - Discussion and Approval of the Donation and Aid Policy Proposed by the Board of Directors | ||||||||||||||||||||||
17 - Informing Shareholders About the Donations and Aid Made by the Company During the Financial Period of January 1, 2024 – December 31, 2024, Without Being Submitted for Voting or Resolution at the General Assembly | ||||||||||||||||||||||
18 - Informing Shareholders About Payments Made Under the Remuneration Policy for Board Members and Executives with Administrative Responsibility, Without Being Submitted for Voting or Resolution at the General Assembly | ||||||||||||||||||||||
19 - Informing the Shareholders that no income and benefit was obtained due to the collaterals, pledges, mortgages and surety granted in favor of third parties, without approval and resolution at the General Assembly. | ||||||||||||||||||||||
20 - Informing the Shareholders regarding the material transactions, which could lead to a conflict of interest with the group or its subsidiaries, of shareholders who hold management control, Members of the Board of Directors, executives with administrative responsibility and their spouses and relatives by blood or affinity up to the second degree and/or performing a trade transaction for him/herself or for a third party that is in group's or its subsidiaries' line of business or becoming an unlimited partner at a partnership that is active in same business lines | ||||||||||||||||||||||
21 - Informing the Shareholders the share buy-backs that were done in accordance with the "Share Buy-back Programme" that was approved shareholders at the General Assembly on March 30, 2022, without approval and resolution at the General Assembly. | ||||||||||||||||||||||
22 - Informing Shareholders About the Updated Disclosure Policy Without Being Submitted for Voting or Resolution at the General Assembly | ||||||||||||||||||||||
23 - Informing Shareholders About the Company's Sustainability Strategy and Activities | ||||||||||||||||||||||
Corporate Actions Involved In Agenda | ||||||||||||||||||||||
| ||||||||||||||||||||||
General Assembly Results | ||||||||||||||||||||||
| ||||||||||||||||||||||
Decisions Regarding Corporate Actions | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Additional Explanations | ||||||||||||||||||||||
- |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.